ZTS- An Attractive Dividend Growth Play in the Animal Health Business

Published 2 months ago Positive
ZTS- An Attractive Dividend Growth Play in the Animal Health Business
Auto
Zoetis Inc. (ZTS) is a global leader in animal health with strong organic growth, robust product innovation, and strategic M&A driving long-term revenue and earnings expansion. The company boasts exceptional dividend safety, a 13-year double-digit dividend growth streak, and a conservative payout ratio, making it ideal for dividend growth investors, explains Prakash Kolli, editor of Dividend Power.

To get more articles and chart analysis from MoneyShow, subscribe to our Top Pros’ Top Picks newsletter here.)

Zoetis' current valuation is slightly below historical averages, presenting an attractive entry point. Despite recent share price declines, Zoetis' market leadership, financial strength, and high dividend growth rate make it a compelling long-term buy.

Zoetis Inc. (ZTS)A graph of a graph showing the number of months AI-generated content may be incorrect.

Zoetis’ declining share price has led to the dividend yield reaching nearly its highest value in the past decade. It exceeds its five-year average of 0.82%. The forward yield is about 1.28%. This suggests an undervalued equity.

Zoetis is a Dividend Contender with a 13-year record of annual double-digit dividend growth. Over the past five years, the growth rate has been around 21.3%. It was slightly less in the past decade, at about 19.6%.

That said, I expect growth to remain robust because of increasing earnings per share and a conservative payout ratio. The firm announced a 16% quarterly increase for investors in December 2024. I expect a similar increase in 2025.

See also:KHC: What I'm Recommending in the Wake of its Split News

Zoetis also receives an “A+” dividend quality grade from Portfolio Insight, ranking it in the 95th percentile. It measures earnings performance, revenue performance, dividend performance, profitability, and financial strength. Investors should be confident about the safety of Zoetis’ dividends.

Recommended Action: Buy ZTS.

More From MoneyShow.com:

Gold: Blasting Higher as Rate Cut Bets Surge Jobs: Taking a Deeper Dive Into the August Data Market Minute 9/8/25: Starlink Shells Out, While PNC Bulks Up

View Comments